Credo Diagnostics Biomedical Pte. Ltd

A RAPID AND PRECISE DIAGNOSTIC TEST FOR THE DETECTION OF COVID-19 IN 20 MINUTES

Coronavirus Disease 2019 (COVID-19) is an acute respiratory illness caused by infection with the SARS-CoV-2, which was initially reported to WHO in Wuhan, China, on December 31, 2019. The SARS-CoV-2 is from the same family of viruses as Severe Acute Respiratory Syndrome (SARS) and spreads from person to person. Virus-laden droplets from an infected person can be transmitted through the nose, eyes, or mouth of another.

The VitaPCR™ SARS-CoV-2 Gen 2 Assay performed on the VitaPCR™ Instrument is a rapid molecular in vitro diagnostic test utilizing a real-time reverse transcription polymerase chain reaction(rRT-PCR) amplification technology for the qualitative detection of SARS-CoV-2 RNA in nasopharyngeal or nasal swabs from patients with signs and symptoms of respiratory infection.

VitaPCR^TM： ACCURATE DIAGNOSTICS, WHENEVER AND WHEREVER YOU NEED IT

Combining a simplified 1 minute hands-on time procedure to ensure seamless integration into practitioners’ workflow, a compact and reliable design that doesn’t require extra equipment like a refrigerator, and a proprietary PCR technology allowing fast and accurate diagnostics, VitaPCR™ allows the detection of SARS-CoV-2 in 20 minutes from sample to results, at the Point-of-Care.

VitaPCR™ empowers practitioners with the right information at the right time, so they can make the right decision and provide the right course of treatment to the patients.

 GENERAL DIAGNOSTIC PROCEDURE

INTUITIVE RESULT INTERPRETATION

Reference

1. Trigt RV, Neat J, Brouwer JL, Hays A, Westerhof H. Deploying a rapid point of care polymerase chain reaction test for SARS-CoV-2 in a clinical research unit to ensure healthy volunteer safety. Bioanalysis. 2021;10.4155/bio-2021-0079.

2. Musumeci A, Vinci M, L'Episcopo F, et al. Implementation of Sample Pooling Procedure Using a Rapid SARS-CoV-2 Diagnostic Real-Time PCR Test Performed Prior to Hospital Admission of People with Intellectual Disabilities. Int J Environ Res Public Health. 2021;18(17):9317.

3. Fournier PE, Edouard S, Wurtz N, et al. Contagion Management at the Méditerranée Infection University Hospital Institute. J Clin Med. 2021;10(12):2627.

4. Fitoussi, F., Dupont, R., Tonen-Wolyec, S., & Bélec, L. (2021). Performances of the VitaPCR™ SARS-CoV-2 Assay during the second wave of the COVID-19 epidemic in France. Journal of medical virology, 93(7), 4351–4357.

5. Fournier PE, Zandotti C, Ninove L, et al. Contribution of VitaPCR SARS-CoV-2 to the emergency diagnosis of COVID-19. J Clin Virol. 2020;133:104682.